Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sproxil is a private technology company that provides product authentication, anti-counterfeiting, supply chain traceability, and consumer engagement solutions, with particularly strong use cases in pharmaceuticals and other regulated products. The company uses mobile, SMS, QR, serialization, and data platforms to help patients, pharmacists, manufacturers, and distributors verify that medicines and other products are authentic. Its offerings include product verification, GS1-aligned supply-chain tracking, and field data collection tools that convert real-world interactions into market intelligence. Sproxil has been active since 2009 and operates commercially across Africa and other emerging markets, serving brands, governments, NGOs, and pharmaceutical companies. In healthcare, its core value proposition is protecting drug authenticity, improving transparency, and reducing counterfeit risk rather than developing therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sproxil.